50 results
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
appropriate acute treatment ... #Prophylaxis #Medications ... #Table #Pharmacology ... #Management #Neurology
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Action, Effects, Clinical ... #Diuretics #Medications ... Pharmacology #summary #table ... #nephrology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... HCQ treatment would ... highlighted circle= clinical ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology #Table
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Managing BPD Clinical ... with ‘treatment ... summarised in Tables ... Personality #Disorder #Medications ... Effectiveness #Table
Approach to Undifferentiated Shock - OnePager Summary
Shock occurs when there is inadequate blood flow (CO) &
essential to determine treatment ... Obstruction (HOCM, critical ... thyrotoxicosis), Medications ... (pancreatitis, low ... diuresis, diuretics), Low
Medication Protocol for Management of Delirium in Older Adults - Always start low and go slow
Olanzapine
Medication Protocol ... - Always start low ... #Delirium #Medications ... Protocol #Geriatrics #Treatment ... #Pharmacology #Table
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Etiology: • Medications ... Elimination (see Table ... STOP offending medications ... acidosis) • Low ... #potassium #nephrology
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
• Peripheral flow ... immunophenotype Clinical ... chemotherapy for low-risk ... disease • Indications ... for Treatment:
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Dosing: 250 mcg tablet ... recommendations for the treatment ... the use of this medication ... eosinophils are low ... won’t have any clinical
Hyperthyroidism Overview

Clinical Manifestation of Hyperthyroidism:
 • Fatigue
 • Weight loss
 • Heat intolerance
 • Depression, nervousness
Hyperthyroidism Overview Clinical ... • Exertional dyspnea ... Diagnosis: • ↓ Low ... ↑ AST/ALT • Treatment ... tenderness Treatment